Koers BioHemp International, Inc.
Aandelen
BKIT
US09076B1052
Farmaceutische producten
Managers | Titel | Leeftijd | Van |
---|---|---|---|
Daniel Blum
CEO | Chief Executive Officer | 35 | 15-05-19 |
Besturend | Titel | Leeftijd | Van |
---|---|---|---|
Daniel Blum
CEO | Chief Executive Officer | 35 | 15-05-19 |
Vaira. 1 jan. | Kapi. | |
---|---|---|
+61,53% | 848 mld. | |
+33,51% | 627 mld. | |
-3,66% | 363 mld. | |
+15,06% | 318 mld. | |
+9,18% | 299 mld. | |
+10,84% | 234 mld. | |
+15,14% | 225 mld. | |
+15,67% | 179 mld. | |
+2,47% | 167 mld. |